Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital
Clinical Infectious Diseases · 04.06.2025 · 80 (5) · 984-991
DOI: 10.1093/cid/ciaf028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 28.02.2025. Verfasst von Sarah N Redmond und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Fidaxomicin, Clostridioides difficile, Clostridium Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, American Rescue Plan Act funds, US Department of Veterans Affairs Office of Research and Development.
Abstract (Originalsprache)
Background
There have been several recent reports of Clostridioides difficile infection (CDI) due to isolates with reduced fidaxomicin susceptibility (minimum inhibitory concentration [MIC] ≥ 2 µg/mL). However, the clinical implications are uncertain because fidaxomicin achieves high concentrations in the intestinal tract.
Methods
In an acute care hospital, we conducted a 3-year cohort study of patients with CDI to determine the frequency of infection with isolates with reduced fidaxomicin susceptibility and the impact on response to fidaxomicin treatment. Stool specimens were cultured for C. difficile, and susceptibility testing was performed using agar dilution. Whole-genome sequencing was used to identify mutations associated with reduced fidaxomicin susceptibility and to determine relatedness of isolates. For genomically related susceptible and reduced susceptibility isolates from the same patient, we compared rates of growth, sporulation, and toxin production.
Results
Of 108 fidaxomicin-treated patients, 6 (5.6%) were infected with isolates that possessed reduced fidaxomicin susceptibility (MICs 8–32 µg/mL), including 3 with initially susceptible isolates followed by clinical failure with subsequent recovery of genomically related isolates with reduced susceptibility. Isolates with reduced fidaxomicin susceptibility harbored mutations in RNA polymerase associated with reduced susceptibility and exhibited reduced toxin production, and 20% to 40% of isolates tested had reduced growth and/or sporulation in comparison with susceptible isolates. Three patients were infected with genomically indistinguishable ribotype 097 isolates with reduced fidaxomicin susceptibility.
Conclusions
Our findings highlight the potential for the emergence on therapy of clinically relevant reduced fidaxomicin susceptibility in C. difficile and its spread via transmission to other patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Research Service, Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, USA.
- Department of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
- Medicine Service, VA Salt Lake City Healthcare System, Salt Lake City, Utah, USA.
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
- Department of Research, Central Texas Veterans Healthcare System, Temple, Texas, USA.
ORCID-Profile: Andrew M Skinner, Amy S Gargis, Chetan Jinadatha, Curtis J Donskey
Förderung
- BLRD VA
- American Rescue Plan Act funds
- US Department of Veterans Affairs Office of Research and Development
- Intramural CDC HHS
Zitieren
APA
Redmond, S. N., Cadnum, J. L., Jencson, A. L., Kaple, C. E., Wilson, B. M., Skinner, A. M., Gargis, A. S., Hwang, M., Choi, H., Chatterjee, P., Jinadatha, C., & Donskey, C. J. (2025). Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital. Clinical Infectious Diseases, 80(5), 984-991. https://doi.org/10.1093/cid/ciaf028
Vancouver
Redmond SN, Cadnum JL, Jencson AL, Kaple CE, Wilson BM, Skinner AM, et al. Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital. Clinical Infectious Diseases. 2025;80(5):984-991. doi:10.1093/cid/ciaf028
BibTeX
@article{Redmond2025,
author = {Redmond, Sarah N and Cadnum, Jennifer L and Jencson, Annette L and Kaple, Claire E and Wilson, Brigid M and Skinner, Andrew M and Gargis, Amy S and Hwang, Munok and Choi, Hosoon and Chatterjee, Piyali and Jinadatha, Chetan and Donskey, Curtis J},
title = {Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital},
journal = {Clinical Infectious Diseases},
year = {2025},
volume = {80},
number = {5},
pages = {984--991},
doi = {10.1093/cid/ciaf028}
}
EUVIMED